Global Blood Therapeutics赞助的临床试验
总计52个结果
-
Global Blood Therapeutics完全的
-
Global Blood Therapeutics完全的
-
University of Illinois at ChicagoGlobal Blood Therapeutics招聘中
-
Immunomolecular Therapeutics, Inc.WCCT Global完全的
-
Alyssum TherapeuticsCBCC Global Research招聘中
-
Anthos Therapeutics, Inc.CYTE Global招聘中
-
GSO Global Clinical Research BVKaryopharm Therapeutics Inc终止
-
GSO Global Clinical Research BVKaryopharm Therapeutics Inc完全的
-
Elizabeth Yang, MD, PhDUniversity of California, San Francisco; Global Blood Therapeutics; Pediatrix完全的
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics, Inc.; Vigeo... 和其他合作者招聘中
-
vTv TherapeuticsNational Heart, Lung, and Blood Institute (NHLBI)终止
-
Windtree TherapeuticsNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
The George Institute for Global Health, ChinaNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Institute of Hematology & Blood Diseases Hospital...Suzhou Fundamenta Therapeutics招聘中
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI); Astellas Pharma Global Development, Inc.完全的
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials...完全的急性髓性白血病美国, 日本, 大韩民国, 台湾, 西班牙, 意大利, 英国, 澳大利亚, 比利时, 加拿大, 丹麦, 法国, 德国, 希腊, 新西兰, 波兰
-
Microvascular Therapeutics, LLCNational Heart, Lung, and Blood Institute (NHLBI); University of Nebraska招聘中
-
Hammond, H. Kirk, M.D.National Heart, Lung, and Blood Institute (NHLBI); Renova Therapeutics完全的
-
University of EdinburghUniversity of Oxford; Latus Therapeutics; Scottish National Blood Transfusion Service (SNBTS)招聘中
-
University of Medicine and Dentistry of New JerseyGlobal Blood Resources, LLC终止
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)完全的骨髓增生异常综合症 | 慢性粒细胞白血病 | 急性双表型白血病 | 缓解期急性髓性白血病 | 缓解期急性淋巴细胞白血病美国
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research Partnership主动,不招人
-
Lisata Therapeutics, Inc.Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Cedars-Sinai Medical Center完全的
-
CF Therapeutics Development Network Coordinating...National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation完全的
-
South West Sydney Local Health DistrictUniversity of Sydney; Lambert Initiative for Cannabinoid Therapeutics招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); Nohla Therapeutics...招聘中造血和淋巴细胞肿瘤 | 急性淋巴细胞白血病 | 骨髓增生异常综合症 | 原始细胞过多的骨髓增生异常综合征 | 慢性粒细胞白血病,BCR-ABL1 阳性 | 急性双表型白血病美国
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); Fred Hutchinson...完全的伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 缓解期成人急性髓性白血病 | 缓解期儿童急性髓性白血病 | 加速期慢性粒细胞白血病 | 缓解期儿童急性淋巴细胞白血病 | 儿童慢性粒细胞白血病 | 儿童骨髓增生异常综合征 | 慢性期慢性粒细胞白血病 | 先前治疗过的骨髓增生异常综合征 | 复发性慢性粒细胞白血病 | 继发性骨髓增生异常综合征 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 新生骨髓增生异常综合征 | 难治性贫血 | 难治性贫血伴原始细胞... 及其他条件美国
-
Seattle Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation; CF Therapeutics...完全的
-
Seattle Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation; CF Therapeutics...完全的
-
Morten Mau-SoerensenHospices Civils de Lyon; Gustave Roussy, Cancer Campus, Grand Paris; Institut Curie; Karyopharm... 和其他合作者未知
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID); National Heart, Lung, and Blood... 和其他合作者完全的
-
Johns Hopkins UniversityEli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); The Cleveland Clinic; National... 和其他合作者完全的
-
Dana-Farber Cancer InstituteJohns Hopkins University; Washington University School of Medicine; National Heart, Lung, and... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US Department of... 和其他合作者完全的
-
Baxalta now part of ShireNational Heart, Lung, and Blood Institute (NHLBI); SAIC-Frederick, Inc.; Cato Research; Therapeutics... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University of Copenhagen; US... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Pfizer; University of Copenhagen; US Department... 和其他合作者终止
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US Department of... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of Copenhagen; US Department... 和其他合作者主动,不招人
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US Department of... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; University of Copenhagen; US... 和其他合作者完全的